OncoImmune
Dr. Zheng co-founded OncoImmune, Inc. while she was a faculty at the Ohio State University and University of Michigan. Dr. Zheng is currently a senior member of the Division of Immunotherapy, Institute of Human Virology and Professor of Surgery, University of Maryland Baltimore, where her lab focuses on the fields of hematopoietic stem cell study, immuno-oncology and cancer biology. Dr. Zheng was trained in anatomic and clinical pathology and is a board-certified Physician with the American Board of Pathology.
This person is not in any offices
OncoImmune
Based in Rockville, Maryland, OncoImmune is a privately-held, clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel biopharmaceuticals for the treatment of cancer and autoimmune disease.